Link available from Synta's homepage. Outstanding news so far. So clear this was a huge overreaction today.
I don't know, but all the doctors on this panel seem very up beat. Most interesting are the doctors saying how good this data is for a lung cancer trial.
I was at the ASCO presentation today at 5:15 and agree the data was well received. Market just overreacted